(Q51382834)

4 April 2018

title

Nateglinide provides tighter glycaemic control than glyburide in patients with Type 2 diabetes with prevalent postprandial hyperglycaemia. (English)

1 reference

4 April 2018

1 reference

1 reference

A Bellomo Damato

1

1 reference

4 April 2018

G Stefanelli

2

1 reference

4 April 2018

L Laviola

3

1 reference

4 April 2018

R Giorgino

4

1 reference

4 April 2018

F Giorgino

5

1 reference

4 April 2018

publication date

1 May 2011

1 reference

4 April 2018

published in

Diabetic Medicine

1 reference

4 April 2018

volume

28

1 reference

4 April 2018

issue

5

1 reference

4 April 2018

page(s)

560-566

1 reference

4 April 2018

The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03219.X

Long-term glycemic control relates to mortality in type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03219.X

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03219.X

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03219.X

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03219.X

Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03219.X

Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03219.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03219.X

Importance of early insulin secretion: comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03219.X

Differential effects of short and long duration insulinotropic agents on meal-related glucose excursions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03219.X

Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03219.X

Four-year impact of a continuous quality improvement effort implemented by a network of diabetes outpatient clinics: the AMD-Annals initiative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03219.X

10.1111/J.1464-5491.2010.03219.X

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018